# High-Dose Ethanol-Induced Immunosuppression Modulates Sex-Specific Disease Outcomes in a Murine Model of Multiple Sclerosis

**Authors:** Adriana S. P. Nuncio, Katherine Motovilov, Max Weed, Simali Shah, Sam Bazzi, Esha Idnani, Turner Lime, Daniela Carrizales Sauceda, Regina A. Mangieri, Cole Maguire, Esther Melamed

PMC · DOI: 10.3390/biom16030427 · Biomolecules · 2026-03-13

## TL;DR

High-dose ethanol reduces autoimmune disease severity in male mice, but causes harmful side effects, suggesting a need for safer alternatives.

## Contribution

The study reveals sex-specific immunosuppressive effects of high-dose ethanol in a mouse model of MS.

## Key findings

- High-dose ethanol reduced peak disease severity in male mice through decreased T cell activation and B cell proportions.
- Ethanol caused proinflammatory gut microbiota shifts and hepatic lipid accumulation.
- Results suggest ethanol's benefits in autoimmunity are offset by systemic toxicity.

## Abstract

Both epidemiological studies and prior work in animal models suggest that moderate-dose alcohol reduces disease severity across several autoimmune conditions, including multiple sclerosis (MS). However, the mechanisms underlying the potentially beneficial effects of alcohol and how these effects may change with alcohol dose in autoimmunity remain underexplored. In this study, we characterize the effects of chronic, high-dose ethanol consumption in experimental autoimmune encephalomyelitis (EAE), a murine model of MS, by examining EAE disease severity, gut microbial composition, and peripheral cell immunophenotypes. We found that high-dose ethanol-fed males exhibited a significant amelioration in peak EAE disease severity, in association with decreased T cell activation and B cell proportions. Concurrently, we observed proinflammatory shifts in gut microbiota and hepatic lipid accumulation. Our results suggest that high dose ethanol may benefit autoimmune neuroinflammation in EAE through immunosuppressive effects on adaptive immunity, however its toxic systemic effects preclude the use of alcohol as an immunomodulator in MS. Overall, our findings reveal a mechanistic basis for alcohol’s beneficial properties in autoimmunity and could inform the development of more targeted disease modifying therapies that recapitulate these benefits without alcohol-associated toxicity.

## Linked entities

- **Chemicals:** ethanol (PubChem CID 702)
- **Diseases:** multiple sclerosis (MONDO:0005301)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** EAE (MESH:D004681), neuroinflammation (MESH:D000090862), toxicity (MESH:D064420), MS (MESH:D009103), autoimmune conditions (MESH:D001327)
- **Chemicals:** Ethanol (MESH:D000431), lipid (MESH:D008055), alcohol (MESH:D000438)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13023817/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13023817/full.md

## References

63 references — full list in the complete paper: https://tomesphere.com/paper/PMC13023817/full.md

---
Source: https://tomesphere.com/paper/PMC13023817